NCT01762293View on ClinicalTrials.gov

A Study of Famitinib in Patients With Advanced Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions
Colorectal CancerColorectal Cancer MetastaticColorectal Cancer Recurrent
Interventions
DRUG

Famitinib

Famitinib 25 mg p.o. qd

OTHER

placebo

p.o. qd

Trial Locations (2)

Unknown

Cancer center, Sun Yet-sen University, Guangzhou

Beijing Cancer Hospital, Peking University, Beijing

All Listed Sponsors
collaborator

Peking University Cancer Hospital & Institute

OTHER

collaborator

Sun Yat-sen University

OTHER

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT01762293 - A Study of Famitinib in Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter